Cite
HARVARD Citation
Ruhlmann, C. et al. (n.d.). 34LBA Fosaprepitant for the prevention of nausea and emesis during five weeks of chemo-radiotherapy: A multinational randomised, placebo-controlled, double-blind trial – the GAND-emesis study. European journal of cancer. pp. S727-. [Online].